JB Chemicals (India) Today

JBCHEPHARM   1,752  7.25  0.42%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
JB Chemicals is trading at 1752.35 as of the 28th of November 2024. This is a 0.42 percent increase since the beginning of the trading day. The stock's open price was 1745.1. JB Chemicals has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for JB Chemicals Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
JB Chemicals is entity of India. It is traded as Stock on NSE exchange. The company has 155.41 M outstanding shares. More on JB Chemicals Pharmaceuticals

Moving against JBCHEPHARM Stock

  0.48REFEX Refex IndustriesPairCorr

JBCHEPHARM Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. JB Chemicals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding JB Chemicals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO DirectorNikhil Chopra
Thematic Ideas
(View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Chemicals Makers, Synthetics, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors)
JB Chemicals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to JB Chemicals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
JB Chemicals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand JB Chemicals' financial leverage. It provides some insight into what part of JB Chemicals' total assets is financed by creditors.
Liquidity
JB Chemicals cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. JB Chemicals Pharmaceuticals has accumulated 3.78 B in total debt. Debt can assist JB Chemicals until it has trouble settling it off, either with new capital or with free cash flow. So, JB Chemicals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like JB Chemicals Pharmac sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for JBCHEPHARM to invest in growth at high rates of return. When we think about JB Chemicals' use of debt, we should always consider it together with cash and equity.

Change In Working Capital

(1.34 Billion)
JB Chemicals Pharmaceuticals (JBCHEPHARM) is traded on National Stock Exchange of India in India and employs 5,311 people. JB Chemicals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 271.92 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate JB Chemicals's market, we take the total number of its shares issued and multiply it by JB Chemicals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. JB Chemicals Pharmac operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 155.41 M outstanding shares. JB Chemicals Pharmaceuticals has accumulated about 269.12 M in cash with 8.01 B of positive cash flow from operations.
Check JB Chemicals Probability Of Bankruptcy
Ownership Allocation
JB Chemicals Pharmac secures a total of 155.41 Million outstanding shares. JB Chemicals Pharmac shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check JBCHEPHARM Ownership Details

JB Chemicals Pharmac Risk Profiles

Although JB Chemicals' alpha and beta are two of the key measurements used to evaluate JB Chemicals' performance over the market, the standard measures of volatility play an important role as well.

JBCHEPHARM Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in JB Chemicals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

JB Chemicals Corporate Management

Elected by the shareholders, the JB Chemicals' board of directors comprises two types of representatives: JB Chemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of JBCHEPHARM. The board's role is to monitor JB Chemicals' management team and ensure that shareholders' interests are well served. JB Chemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, JB Chemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Amin SureshAssistant ResourceProfile
Jason DSouzaExecutive RelationsProfile
Milind JoshiPres AffairsProfile
Sridhar BharadwajVice AdministrationProfile
Lakshay KatariaChief OfficerProfile
Himanshu RanvahVice LegalProfile

Other Information on Investing in JBCHEPHARM Stock

JB Chemicals financial ratios help investors to determine whether JBCHEPHARM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in JBCHEPHARM with respect to the benefits of owning JB Chemicals security.